BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
BINV | ST
Overview
Corporate Details
- ISIN(s):
- SE0015244520
- LEI:
- 549300E7QRHEF2IJUY10
- Country:
- Sweden
- Address:
- C/O BioInvent International Aktiebolag, 223 70 Lund
- Website:
- https://www.bioinvent.com/en
- Sector:
- Manufacturing
Description
BioInvent International is a clinical-stage company that discovers and develops novel, first-in-class immuno-modulatory antibodies for cancer therapy. Leveraging extensive expertise in immunology, cancer biology, and antibody biology, the company generates innovative immuno-oncology drug candidates for its clinical pipeline. BioInvent's operations include an in-house manufacturing facility to produce antibodies for its preclinical studies and clinical trials, with the goal of developing treatments that can transform the lives of cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-01 07:30 |
BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of nove…
|
English | 191.6 KB | ||
| 2021-02-26 08:00 |
Change in the number of shares and votes in BioInvent International AB
|
English | 72.3 KB | ||
| 2021-02-26 08:00 |
Ändring av antalet aktier och röster i BioInvent International AB
|
Swedish | 73.7 KB | ||
| 2021-02-23 08:30 | Swedish | 539.9 KB | |||
| 2021-02-23 08:30 | English | 555.9 KB | |||
| 2021-02-23 06:45 |
BioInvent International AB brings forward publication of Year-end report 2020
|
English | 106.8 KB | ||
| 2021-02-23 06:45 |
BioInvent International AB tidigarelägger publicering av bokslutskommuniké 2020
|
Swedish | 107.5 KB | ||
| 2021-02-23 06:30 |
BioInvent successfully carries out a directed share issue of approximately SEK …
|
English | 219.7 KB | ||
| 2021-02-23 06:30 |
BioInvent genomför framgångsrikt en riktad nyemission om cirka 962 MSEK (cirka …
|
Swedish | 214.3 KB | ||
| 2021-01-28 07:45 |
BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in re…
|
English | 83.2 KB | ||
| 2021-01-28 07:45 |
BioInvents fas I/IIa-data tyder på att BI-1206 återställer effekten av rituxima…
|
Swedish | 83.3 KB | ||
| 2021-01-18 08:30 |
An van Es Johansson resigns as board director in BioInvent International AB
|
English | 89.6 KB | ||
| 2021-01-18 08:30 |
An van Es Johansson avgår som styrelseledamot i BioInvent International AB
|
Swedish | 92.0 KB | ||
| 2021-01-11 08:15 |
BioInvent reviderar avtal avseende anti-Fc?RllB-antikroppen BI-1206, före data …
|
Swedish | 111.1 KB | ||
| 2021-01-11 08:15 |
BioInvent streamlines agreement on anti-Fc?RllB antibody, BI-1206, ahead of Pha…
|
English | 98.0 KB |
Automate Your Workflow. Get a real-time feed of all BioInvent International filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioInvent International
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioInvent International via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-09 | Erik Esveld | Other | Buy | 4,000 | 70,960.00 SEK |
| 2023-06-30 | Sylvie Ryckebusch | Other | Buy | 5,000 | 7,890.00 EUR |
| 2022-11-16 | Dharminder Chahal | Other | Buy | 10,000 | 352,500.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 3,262 | 109,798.92 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 800 | 27,200.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 750 | 25,425.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 611 | 20,700.68 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 530 | 17,193.20 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 500 | 16,800.00 SEK |
| 2022-03-09 | Martin Welschof | Other | Buy | 400 | 13,712.00 SEK |
Peer Companies
